STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination
Open Access
- 9 March 2020
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 117 (10), 5430-5441
- https://doi.org/10.1073/pnas.1913997117
Abstract
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous system. Dysregulation of STAT3, a transcription factor pivotal to various cellular processes including Th17 cell differentiation, has been implicated in MS. Here, we report that STAT3 is activated in infiltrating monocytic cells near active MS lesions and that activation of STAT3 in myeloid cells is essential for leukocyte infiltration, neuroinflammation, and demyelination in experimental autoimmune encephalomyelitis (EAE). Genetic disruption of Stat3 in peripheral myeloid lineage cells abrogated EAE, which was associated with decreased antigen-specific T helper cell responses. Myeloid cells from immunized Stat3 mutant mice exhibited impaired antigen-presenting functions and were ineffective in driving encephalitogenic T cell differentiation. Single-cell transcriptome analyses of myeloid lineage cells from preclinical wild-type and mutant mice revealed that loss of myeloid STAT3 signaling disrupted antigen-dependent cross-activation of myeloid cells and T helper cells. This study identifies a previously unrecognized requisite for myeloid cell STAT3 in the activation of myelinreactive T cells and suggests myeloid STAT3 as a potential therapeutic target for autoimmune demyelinating disease.Funding Information
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS060017)
- National Multiple Sclerosis Society (RG3975)
- National Multiple Sclerosis Society (RG1507)
This publication has 61 references indexed in Scilit:
- Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammationProceedings of the National Academy of Sciences of the United States of America, 2012
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisNature, 2011
- ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recyclingBlood, 2010
- Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 GeneAmerican Journal of Human Genetics, 2010
- Localizing central nervous system immune surveillance: Meningeal antigen‐presenting cells activate T cells during experimental autoimmune encephalomyelitisAnnals of Neurology, 2009
- Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating diseaseBlood, 2009
- Pathway and network-based analysis of genome-wide association studies in multiple sclerosisHuman Molecular Genetics, 2009
- Multiple sclerosisThe Lancet, 2008
- Cytokine Signaling Modules in Inflammatory ResponsesImmunity, 2008
- Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitisThe Journal of Experimental Medicine, 2006